NO862689L - Dehydratisert kapsel, samt fremgangsmaate for fremstilling av en slik. - Google Patents
Dehydratisert kapsel, samt fremgangsmaate for fremstilling av en slik. Download PDFInfo
- Publication number
- NO862689L NO862689L NO862689A NO862689A NO862689L NO 862689 L NO862689 L NO 862689L NO 862689 A NO862689 A NO 862689A NO 862689 A NO862689 A NO 862689A NO 862689 L NO862689 L NO 862689L
- Authority
- NO
- Norway
- Prior art keywords
- capsules
- membrane
- solution
- capsule
- substance
- Prior art date
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 149
- 238000000034 method Methods 0.000 title claims abstract description 40
- 239000012528 membrane Substances 0.000 claims abstract description 50
- 239000000203 mixture Substances 0.000 claims abstract description 11
- 230000035699 permeability Effects 0.000 claims abstract description 11
- 239000012024 dehydrating agents Substances 0.000 claims abstract description 9
- 238000005406 washing Methods 0.000 claims abstract description 8
- 239000007788 liquid Substances 0.000 claims abstract description 7
- 239000000243 solution Substances 0.000 claims description 50
- 238000011049 filling Methods 0.000 claims description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 26
- 239000000463 material Substances 0.000 claims description 14
- 239000007864 aqueous solution Substances 0.000 claims description 10
- 238000000576 coating method Methods 0.000 claims description 9
- 239000011248 coating agent Substances 0.000 claims description 8
- 230000003204 osmotic effect Effects 0.000 claims description 8
- 108010055896 polyornithine Proteins 0.000 claims description 8
- 229920002714 polyornithine Polymers 0.000 claims description 8
- 239000003960 organic solvent Substances 0.000 claims description 7
- 239000000017 hydrogel Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 230000003111 delayed effect Effects 0.000 claims description 4
- 108010039918 Polylysine Proteins 0.000 claims description 3
- 229920000656 polylysine Polymers 0.000 claims description 3
- 108010040003 polyglutamine Proteins 0.000 claims description 2
- 229920000155 polyglutamine Polymers 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 239000000126 substance Substances 0.000 abstract description 57
- 239000013543 active substance Substances 0.000 abstract description 8
- 239000003814 drug Substances 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 5
- 239000003094 microcapsule Substances 0.000 description 29
- 238000006297 dehydration reaction Methods 0.000 description 12
- 239000011148 porous material Substances 0.000 description 12
- 230000018044 dehydration Effects 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 8
- 229940098773 bovine serum albumin Drugs 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 239000002904 solvent Substances 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 5
- 238000009792 diffusion process Methods 0.000 description 4
- 229920002851 polycationic polymer Polymers 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 244000309466 calf Species 0.000 description 3
- 229920001688 coating polymer Polymers 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 229920000447 polyanionic polymer Polymers 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000003828 vacuum filtration Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 102000036675 Myoglobin Human genes 0.000 description 2
- 108010062374 Myoglobin Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- -1 antibodies Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- NEPLKJAINOWIJL-DHNNRRLOSA-N dnc014884 Polymers C1C2=CC3=CC=CC=C3N2[C@@]2(C)[C@@H]1[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1CC2 NEPLKJAINOWIJL-DHNNRRLOSA-N 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000008072 Lymphokines Human genes 0.000 description 1
- 108010074338 Lymphokines Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OZJHCMYAXLCFKU-UHFFFAOYSA-N Polyavolensinone Natural products CC1(C)C2CCC3n4c(CC3(C)C2(C)CCC1=O)cc5ccccc45 OZJHCMYAXLCFKU-UHFFFAOYSA-N 0.000 description 1
- 229920001284 acidic polysaccharide Polymers 0.000 description 1
- 150000004805 acidic polysaccharides Chemical class 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 238000005429 filling process Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/20—After-treatment of capsule walls, e.g. hardening
- B01J13/203—Exchange of core-forming material by diffusion through the capsule wall
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Fats And Perfumes (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/752,384 US4683092A (en) | 1985-07-03 | 1985-07-03 | Capsule loading technique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO862689D0 NO862689D0 (no) | 1986-07-02 |
| NO862689L true NO862689L (no) | 1987-01-05 |
Family
ID=25026104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO862689A NO862689L (no) | 1985-07-03 | 1986-07-02 | Dehydratisert kapsel, samt fremgangsmaate for fremstilling av en slik. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4683092A (enExample) |
| EP (1) | EP0207655B1 (enExample) |
| JP (2) | JPS627441A (enExample) |
| AT (1) | ATE46625T1 (enExample) |
| CA (1) | CA1268117A (enExample) |
| DE (1) | DE3665818D1 (enExample) |
| DK (1) | DK304186A (enExample) |
| NO (1) | NO862689L (enExample) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4880635B1 (en) * | 1984-08-08 | 1996-07-02 | Liposome Company | Dehydrated liposomes |
| JPH0753656B2 (ja) * | 1986-05-14 | 1995-06-07 | ライオン株式会社 | 浴用組成物 |
| US4997599A (en) * | 1987-12-08 | 1991-03-05 | Celanese Fibers Inc. | Preparation of water soluble cellulose acetate microspheres |
| US4970031A (en) * | 1988-06-02 | 1990-11-13 | Nok Corporation | Process for preparing microcapsules with controlled-release |
| JP2733087B2 (ja) * | 1989-03-29 | 1998-03-30 | 花王株式会社 | 中空ポリマー微粒子及びその製造方法並びにその用途 |
| JPH02258052A (ja) * | 1989-03-31 | 1990-10-18 | Mita Ind Co Ltd | 芯物質の保持性に優れた含水マイクロカプセルの製造方法 |
| JPH02258053A (ja) * | 1989-03-31 | 1990-10-18 | Mita Ind Co Ltd | 単核含水マイクロカプセルの製造方法 |
| GB8926320D0 (en) * | 1989-11-21 | 1990-01-10 | Univ Strathclyde | Production of microparticles |
| US5305757A (en) * | 1989-12-22 | 1994-04-26 | Unger Evan C | Gas filled liposomes and their use as ultrasonic contrast agents |
| US5578323A (en) | 1992-06-15 | 1996-11-26 | Emisphere Technologies, Inc. | Proteinoid carriers and methods for preparation and use thereof |
| US6221367B1 (en) | 1992-06-15 | 2001-04-24 | Emisphere Technologies, Inc. | Active agent transport systems |
| US5714167A (en) | 1992-06-15 | 1998-02-03 | Emisphere Technologies, Inc. | Active agent transport systems |
| US6099856A (en) * | 1992-06-15 | 2000-08-08 | Emisphere Technologies, Inc. | Active agent transport systems |
| US5693338A (en) * | 1994-09-29 | 1997-12-02 | Emisphere Technologies, Inc. | Diketopiperazine-based delivery systems |
| US6461643B2 (en) * | 1993-04-22 | 2002-10-08 | Emisphere Technologies, Inc. | Oral drug delivery compositions and methods |
| US6090958A (en) * | 1995-03-31 | 2000-07-18 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| CN1151836C (zh) * | 1995-03-31 | 2004-06-02 | 艾米斯菲尔技术有限公司 | 用作传送活性剂的化合物和组合物 |
| US5989539A (en) * | 1995-03-31 | 1999-11-23 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| US6001347A (en) | 1995-03-31 | 1999-12-14 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| US5750147A (en) | 1995-06-07 | 1998-05-12 | Emisphere Technologies, Inc. | Method of solubilizing and encapsulating itraconazole |
| WO1997010197A1 (en) * | 1995-09-11 | 1997-03-20 | Emisphere Technologies, Inc. | METHOD FOR PREPARING φ-AMINOALKANOIC ACID DERIVATIVES FROM CYCLOALKANONES |
| US6447800B2 (en) | 1996-01-18 | 2002-09-10 | The University Of British Columbia | Method of loading preformed liposomes using ethanol |
| AU2595697A (en) | 1996-03-29 | 1997-10-22 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| WO1997047288A1 (en) | 1996-06-14 | 1997-12-18 | Emisphere Technologies, Inc. | Microencapsulated fragrances and method for preparation |
| US5891474A (en) | 1997-01-29 | 1999-04-06 | Poli Industria Chimica, S.P.A. | Time-specific controlled release dosage formulations and method of preparing same |
| US5804688A (en) * | 1997-02-07 | 1998-09-08 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| US6060513A (en) * | 1997-02-07 | 2000-05-09 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| US6358504B1 (en) | 1997-02-07 | 2002-03-19 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| US6313088B1 (en) | 1997-02-07 | 2001-11-06 | Emisphere Technologies, Inc. | 8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents |
| US5990166A (en) * | 1997-02-07 | 1999-11-23 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| US5773647A (en) * | 1997-02-07 | 1998-06-30 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| US5863944A (en) * | 1997-04-30 | 1999-01-26 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| US5962710A (en) * | 1997-05-09 | 1999-10-05 | Emisphere Technologies, Inc. | Method of preparing salicyloylamino acids |
| US6030641A (en) * | 1997-06-03 | 2000-02-29 | Uni Colloid Kabushiki Kaisha | Sustained release capsule and method for preparing the same |
| US20010003580A1 (en) | 1998-01-14 | 2001-06-14 | Poh K. Hui | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
| DK1064087T3 (da) * | 1998-03-19 | 2006-05-29 | Max Planck Gesellschaft | Fremstilling af nano- og mikrokapsler ved lagvis polyelektrolyt-selvassemblering |
| US7101575B2 (en) * | 1998-03-19 | 2006-09-05 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly |
| US6701637B2 (en) | 2001-04-20 | 2004-03-09 | Kimberly-Clark Worldwide, Inc. | Systems for tissue dried with metal bands |
| US20040219268A1 (en) * | 2001-08-03 | 2004-11-04 | Ingmar Hogoy | Encapsulation |
| AU2003251858A1 (en) * | 2002-07-11 | 2004-02-02 | Targeson, Llc | Microbubble compositions, and methods for preparing and using same |
| DE102004013637A1 (de) * | 2004-03-19 | 2005-10-13 | Capsulution Nanoscience Ag | Verfahren zur Herstellung von CS-Partikeln und Mikrokapseln unter Verwendung poröser Template sowie CS-Partikel und Mikrokapseln |
| ITRM20080037A1 (it) | 2008-01-23 | 2009-07-24 | Uni Degli Studi Perugia | Procedimento per la ultrapurificazione di alginati. |
| JP5443780B2 (ja) * | 2009-02-20 | 2014-03-19 | 積水化学工業株式会社 | イミダゾール化合物を内包した微粒子の製造方法 |
| AU2010314994B2 (en) | 2009-11-09 | 2016-10-06 | Spotlight Technology Partners Llc | Fragmented hydrogels |
| JP5864429B2 (ja) | 2009-11-09 | 2016-02-17 | スポットライト テクノロジー パートナーズ エルエルシーＳｐｏｔｌｉｇｈｔ Ｔｅｃｈｎｏｌｏｇｙ Ｐａｒｔｎｅｒｓ Ｌｌｃ | 架橋ヒドロゲル組成物、ヒドロゲル組成物の形成方法、及びキット |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3516942A (en) * | 1966-09-27 | 1970-06-23 | Ncr Co | Process for drying capsule walls of hydrophilic polymeric material |
| US3516943A (en) * | 1966-12-06 | 1970-06-23 | Ncr Co | Replacement of capsule contents by diffusion |
| US3657144A (en) * | 1967-06-05 | 1972-04-18 | Ncr Co | Encapsulation process |
| US3639306A (en) * | 1968-08-08 | 1972-02-01 | Amicon Corp | Encapsulating particles and process for making same |
| US3664963A (en) * | 1969-10-22 | 1972-05-23 | Balchem Corp | Encapsulation process |
| US3780195A (en) * | 1969-10-22 | 1973-12-18 | Balchem Corp | Encapsulation process |
| US3657143A (en) * | 1970-02-02 | 1972-04-18 | Ncr Co | Manufacture of minute capsules enmasse and dewatering their walls |
| US3639036A (en) * | 1970-04-13 | 1972-02-01 | Edward J Rosebach Jr | Light-reflective wheel covers |
| JPS5211184A (en) * | 1975-07-17 | 1977-01-27 | Yoshiaki Motozato | Two-layer spherical gel particles for molecular sieve |
| US4324683A (en) * | 1975-08-20 | 1982-04-13 | Damon Corporation | Encapsulation of labile biological material |
| JPS5248574A (en) * | 1975-10-16 | 1977-04-18 | Toyo Jozo Co Ltd | Process for refining |
| JPS6017573B2 (ja) * | 1977-05-04 | 1985-05-04 | 神崎製紙株式会社 | マイクロカプセル水性分散液の製造法 |
| JPS588292B2 (ja) * | 1978-03-09 | 1983-02-15 | 工業技術院長 | マイクロカプセルの調製方法 |
| US4272398A (en) * | 1978-08-17 | 1981-06-09 | The United States Of America As Represented By The Secretary Of Agriculture | Microencapsulation process |
| US4391909A (en) * | 1979-03-28 | 1983-07-05 | Damon Corporation | Microcapsules containing viable tissue cells |
| US4389330A (en) * | 1980-10-06 | 1983-06-21 | Stolle Research And Development Corporation | Microencapsulation process |
| US4389419A (en) * | 1980-11-10 | 1983-06-21 | Damon Corporation | Vitamin encapsulation |
| FR2521565B1 (fr) * | 1982-02-17 | 1985-07-05 | Dior Sa Parfums Christian | Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees |
| AU567155B2 (en) * | 1983-04-15 | 1987-11-12 | Damon Biotech Inc. | Capsules for releasing core material at constant rate |
| US4515736A (en) * | 1983-05-12 | 1985-05-07 | The Regents Of The University Of California | Method for encapsulating materials into liposomes |
| JPS6034731A (ja) * | 1983-08-04 | 1985-02-22 | Kohjin Co Ltd | 新規なマイクロカプセルとその製造方法 |
| US4492720A (en) * | 1983-11-15 | 1985-01-08 | Benjamin Mosier | Method of preparing microspheres for intravascular delivery |
-
1985
- 1985-07-03 US US06/752,384 patent/US4683092A/en not_active Expired - Fee Related
-
1986
- 1986-04-29 CA CA000507919A patent/CA1268117A/en not_active Expired - Lifetime
- 1986-06-10 DE DE8686304415T patent/DE3665818D1/de not_active Expired
- 1986-06-10 AT AT86304415T patent/ATE46625T1/de not_active IP Right Cessation
- 1986-06-10 EP EP86304415A patent/EP0207655B1/en not_active Expired
- 1986-06-20 JP JP61144663A patent/JPS627441A/ja active Granted
- 1986-06-26 DK DK304186A patent/DK304186A/da not_active Application Discontinuation
- 1986-07-02 NO NO862689A patent/NO862689L/no unknown
-
1990
- 1990-03-12 JP JP2060867A patent/JPH02290241A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0516900B2 (enExample) | 1993-03-05 |
| US4683092A (en) | 1987-07-28 |
| EP0207655A1 (en) | 1987-01-07 |
| JPH02290241A (ja) | 1990-11-30 |
| DK304186A (da) | 1987-01-04 |
| JPS627441A (ja) | 1987-01-14 |
| CA1268117A (en) | 1990-04-24 |
| ATE46625T1 (de) | 1989-10-15 |
| NO862689D0 (no) | 1986-07-02 |
| EP0207655B1 (en) | 1989-09-27 |
| DK304186D0 (da) | 1986-06-26 |
| DE3665818D1 (en) | 1989-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4683092A (en) | Capsule loading technique | |
| US4690682A (en) | Sustained release | |
| CA1230054A (en) | Sustained release semi-permeable capsule | |
| CA1246447A (en) | Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use | |
| Briššová et al. | Control and measurement of permeability for design of microcapsule cell delivery system | |
| US4923645A (en) | Sustained release of encapsulated molecules | |
| US6087003A (en) | Method of coating particles and coated spherical particles | |
| JP5060128B2 (ja) | ポリウレタンを基とするポリマーを用いた長期薬物輸送装置の製造 | |
| US4789516A (en) | Production of sustained released system | |
| US20040013738A1 (en) | Encapsulation of liquid template particles | |
| NO850535L (no) | Fremgangsmaate for innkapsling av et kjernemateriale | |
| JP2002538194A (ja) | 生体活性物質用細胞保護生体適合封入系及びその製造方法 | |
| AU705108B2 (en) | Novel encapsulation process by a gelling polymer | |
| CN105709671B (zh) | 一种聚电解质微囊的制备方法 | |
| US4749576A (en) | Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use | |
| Dembczynski et al. | Determination of pore diameter and molecular weight cut-off of hydrogel-membrane liquid-core capsules for immunoisolation | |
| NO131417B (enExample) | ||
| US4379038A (en) | Process for preparing a physiologically active substance controlled release composite composition | |
| Sakai et al. | Permeability of alginate/sol–gel synthesized aminopropyl-silicate/alginate membrane templated by calcium-alginate gel | |
| Park et al. | Ca-alginate microspheres encapsulated in chitosan beads | |
| Carelli et al. | Evaluation of a silicone based matrix containing a crosslinked polyethylene glycol as a controlled drug delivery system for potential oral application | |
| NO127792B (enExample) | ||
| JPH0249718A (ja) | リポソーム製剤の精製法 | |
| CN101439202B (zh) | 明胶-壳聚糖球形多孔颗粒材料及其制备方法和装置 | |
| Kalmár | Aerogels in drug delivery: From design to application |